Avidity Biosciences
115 hedge funds and large institutions have $757M invested in Avidity Biosciences in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.12% less ownership
Funds ownership: 106.91% → 104.79% (-2.1%)
30% less capital invested
Capital invested by funds: $1.09B → $757M (-$328M)
Holders
115
Holding in Top 10
2
Calls
$3.46M
Puts
$2K
Top Buyers
| 1 | +$32.9M | |
| 2 | +$9.67M | |
| 3 | +$5.71M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.85M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.71M |
Top Sellers
| 1 | -$54.8M | |
| 2 | -$1.49M | |
| 3 | -$1.35M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$981K |
| 5 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
-$792K |